Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:1666-1670

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirashima, Y.
Right arrow Articles by Takaku, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirashima, Y.
Right arrow Articles by Takaku, A.

(Stroke. 1997;28:1666-1670.)
© 1997 American Heart Association, Inc.


Articles

Cerebrospinal Fluid Tissue Factor and Thrombin-Antithrombin III Complex as Indicators of Tissue Injury After Subarachnoid Hemorrhage

Yutaka Hirashima, MD; Shin Nakamura, PhD; Michiyasu Suzuki, MD; Masanori Kurimoto, MD; Shunro Endo, MD; Akira Ogawa, MD; Akira Takaku, MD

From the Department of Neurosurgery, Toyama Medical and Pharmaceutical University (Y.H., M.K., S.E., A.T.), Toyami-shi, Toyama; Department of Cell and Molecular Biology, Primate Research Institute, Kyoto University (S.N.), Inuyama-shi, Aichi; and Department of Neurosurgery, Iwate Medical University (M.S., A.O.), Morioka-shi, Iwate, Japan.

Correspondence and reprint requests to Dr Yutaka Hirashima, Department of Neurosurgery, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan. E-mail yhira{at}ms.toyama-mpu.ac.jp.

Background and Purpose No marker that reflects and predicts brain injury due to subarachnoid hemorrhage (SAH) and cerebral vasospasm has been reported. We hypothesized that membrane-bound tissue factor (mTF) and thrombin–antithrombin III complex (TAT) in the cerebrospinal fluid (CSF) of patients with SAH become markers indicating brain injury. To evaluate the hypothesis, we correlated levels of mTF and TAT in the CSF of patients with SAH with clinical severity, the degree of SAH, and outcome.

Methods We assayed CSF mTF, TAT and myelin basic protein (MBP) in patients with SAH at intervals that included days 0 to 4 and days 5 to 9 after ictus. Classification of clinical severity of disease on admission was based on Hunt and Hess grade, degree of SAH on CT on Fisher's grading, and outcome 3 months after SAH on the Glasgow Outcome Scale.

Results In the interval from days 0 to 4, mTF and TAT correlated with Hunt and Hess and Fisher grades, and occurrence of cerebral infarction due to vasospasm. Only mTF correlated significantly in this period with outcome. TAT, mTF, and MBP all correlated significantly with each other. From days 5 to 9, only mTF correlated with cerebral infarction, infarction volume, MBP levels, and outcome.

Conclusions Both mTF and TAT reflected brain injury from SAH and predicted vasospasm, though mTF was more sensitive and a better predictor of outcome. Unlike mTF, TAT did not correlate with vasospasm during the interval when it most commonly occurs, which raised doubt about thrombin activation as a cause.


Key Words: cerebral vasospasm • procoagulants • subarachnoid hemorrhage • cerebrospinal fluid • thrombin




This article has been cited by other articles:


Home page
StrokeHome page
H. Tsurutani, H. Ohkuma, and S. Suzuki
Effects of Thrombin Inhibitor on Thrombin-Related Signal Transduction and Cerebral Vasospasm in the Rabbit Subarachnoid Hemorrhage Model
Stroke, June 1, 2003; 34(6): 1497 - 1500.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Z. Zhang, I. Nagata, H. Kikuchi, J-H. Xue, N. Sakai, H. Sakai, and H. Yanamoto
Broad-Spectrum and Selective Serine Protease Inhibitors Prevent Expression of Platelet-Derived Growth Factor-BB and Cerebral Vasospasm After Subarachnoid Hemorrhage : Vasospasm Caused by Cisternal Injection of Recombinant Platelet-Derived Growth Factor-BB
Stroke, July 1, 2001; 32(7): 1665 - 1672.
[Abstract] [Full Text] [PDF]